MX2014013754A - Metodos de cristalizacion para la purificacion de anticuerpos monoclonales. - Google Patents

Metodos de cristalizacion para la purificacion de anticuerpos monoclonales.

Info

Publication number
MX2014013754A
MX2014013754A MX2014013754A MX2014013754A MX2014013754A MX 2014013754 A MX2014013754 A MX 2014013754A MX 2014013754 A MX2014013754 A MX 2014013754A MX 2014013754 A MX2014013754 A MX 2014013754A MX 2014013754 A MX2014013754 A MX 2014013754A
Authority
MX
Mexico
Prior art keywords
purification
monoclonal antibodies
crystallization methods
crystallization
methods
Prior art date
Application number
MX2014013754A
Other languages
English (en)
Spanish (es)
Inventor
Dariusch Hekmat
Bernhard Helk
Henk Konrad Schulz
Benjamin Smejkal
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2014013754A publication Critical patent/MX2014013754A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/306Extraction; Separation; Purification by precipitation by crystallization
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Botany (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2014013754A 2012-05-11 2013-05-10 Metodos de cristalizacion para la purificacion de anticuerpos monoclonales. MX2014013754A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261645855P 2012-05-11 2012-05-11
PCT/EP2013/059696 WO2013167720A1 (en) 2012-05-11 2013-05-10 Crystallization methods for purification of monoclonal antibodies

Publications (1)

Publication Number Publication Date
MX2014013754A true MX2014013754A (es) 2015-02-12

Family

ID=48326319

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013754A MX2014013754A (es) 2012-05-11 2013-05-10 Metodos de cristalizacion para la purificacion de anticuerpos monoclonales.

Country Status (14)

Country Link
US (2) US20150133642A1 (en:Method)
EP (1) EP2846830A1 (en:Method)
JP (1) JP2015517306A (en:Method)
KR (1) KR20150016503A (en:Method)
CN (1) CN104284676B (en:Method)
AU (1) AU2013258006B2 (en:Method)
BR (1) BR112014027994A2 (en:Method)
CA (1) CA2872145A1 (en:Method)
IL (1) IL235483A0 (en:Method)
IN (1) IN2014DN09097A (en:Method)
MX (1) MX2014013754A (en:Method)
RU (1) RU2014150071A (en:Method)
SG (1) SG11201406664SA (en:Method)
WO (1) WO2013167720A1 (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
KR20250035606A (ko) * 2016-12-23 2025-03-12 아를라 푸즈 에이엠비에이 신규 베타-락토글로불린 제제의 제조 및 관련 방법, 용도 및 식료품
JP7229933B2 (ja) * 2017-03-14 2023-02-28 アムジェン インコーポレイテッド 結晶性生体分子を対象にする方法
JP7467364B2 (ja) 2018-06-27 2024-04-15 アーラ フーズ エイエムビーエイ ベータ-ラクトグロブリン単離物を製造するためのプロセス、並びに関連する方法及び使用
IT202100004496A1 (it) 2021-02-25 2022-08-25 Univ Della Calabria Recupero di farmaci biologici o loro frammenti da soluzioni impure mediante cristallizzazione o precipitazione con membrane
CN116949036B (zh) * 2023-09-11 2023-12-15 成都斯马特科技有限公司 一种快速从腹水中提取核酸的试剂盒及提取方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100031769A (ko) * 2000-12-28 2010-03-24 알투스 파마슈티컬스 인코포레이티드 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
ATE482716T1 (de) * 2001-11-13 2010-10-15 Genentech Inc Zusammensetzungen basierend auf apo2-ligand/ trail und ihre verwendung
US7087719B2 (en) * 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin
CN101945890A (zh) * 2007-12-21 2011-01-12 健泰科生物技术公司 抗cd20抗体的结晶
CN101320006B (zh) * 2008-07-17 2010-12-01 西北工业大学 蛋白质结晶条件的筛选方法

Also Published As

Publication number Publication date
AU2013258006A1 (en) 2014-11-06
KR20150016503A (ko) 2015-02-12
WO2013167720A1 (en) 2013-11-14
RU2014150071A (ru) 2016-07-10
JP2015517306A (ja) 2015-06-22
US20170198028A1 (en) 2017-07-13
CA2872145A1 (en) 2013-11-14
SG11201406664SA (en) 2014-11-27
CN104284676A (zh) 2015-01-14
EP2846830A1 (en) 2015-03-18
CN104284676B (zh) 2018-11-27
BR112014027994A2 (pt) 2017-06-27
IN2014DN09097A (en:Method) 2015-05-22
IL235483A0 (en) 2014-12-31
US20150133642A1 (en) 2015-05-14
AU2013258006B2 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
EP3674320A3 (en) Production of heterodimeric proteins
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
UY34206A (es) Anticuerpo monoclonal de interleucina-31
UY34394A (es) Polipéptidos de anticuerpos que antagonizan cd40l
IL242649A (en) Purification process of monoclonal antibody
PT2768857T (pt) Métodos para purificar anticorpos
SG11201505192RA (en) Chromatographic purification of antibodies from chromatin-deficient cell culture harvests
GB201103836D0 (en) Conjugation process
MX342851B (es) Metodos y materiales para sintesis enzimatica de compuestos mogrosido.
ZA201509334B (en) Improved process for production of monoclonal antibodies
EA201391389A1 (ru) Кристаллы антител против склеростина и составы на их основе
EP2982742A4 (en) PHOTOBIOREACTOR FOR THE MASS CULTIVATION OF PHOTOSYNTHESEMICROORGANISM
IN2014DN08481A (en:Method)
UY34343A (es) Proteinas de unión al antígeno cd27l
NZ703973A (en) Complex chromosome engineering for production of human antibodies in transgenic animals
SA515361251B1 (ar) طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين
NZ705606A (en) Methods for identifying antibodies with reduced immunogenicity
MX2014002996A (es) Anticuerpos anti - egfr/anti - igf-1r bisespecificos.
MX2014013754A (es) Metodos de cristalizacion para la purificacion de anticuerpos monoclonales.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
IN2014DN09451A (en:Method)
EP2683740A4 (en) GENERATION OF ANTI-FN14 MONOCLONAL ANTIBODIES BY ACCELERATED DEVELOPMENT OF EX-VIVO ANTIBODIES
EP2714713A4 (en) PURIFICATION OF ANTIBODIES
MX2014002378A (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.